Cargando…

Polymorphisms of Homologous Recombination Genes and Clinical Outcomes of Non-Small Cell Lung Cancer Patients Treated with Definitive Radiotherapy

The repair of DNA double-strand breaks (DSBs) is the major mechanism to maintain genomic stability in response to irradiation. We hypothesized that genetic polymorphisms in DSB repair genes may affect clinical outcomes among non-small cell lung cancer (NSCLC) patients treated with definitive radio(c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Ming, Liao, Zhongxing, Huang, Yu-Jing, Liu, Zhensheng, Yuan, Xianglin, Gomez, Daniel, Wang, Li-E, Wei, Qingyi
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3102071/ https://www.ncbi.nlm.nih.gov/pubmed/21647442 http://dx.doi.org/10.1371/journal.pone.0020055

Ejemplares similares

TGFβ1 Polymorphisms Predict Distant Metastasis–Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy
por: Yuan, Xianglin, et al.
Publicado: (2013)

Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy
por: Guan, Xiaoxiang, et al.
Publicado: (2010)

Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer
por: Yang, Ju, et al.
Publicado: (2017)

The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non–Small Cell Lung Cancer (NSCLC) Receiving Definitive Radiotherapy()()()
por: Yang, Ju, et al.
Publicado: (2017)

TNFRSF1B +676 T>G polymorphism predicts survival of non-Small cell lung cancer patients treated with chemoradiotherapy
por: Guan, Xiaoxiang, et al.
Publicado: (2011)

Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non‐small cell lung cancer
por: Yang, Ju, et al.
Publicado: (2018)

Homologous Recombination Deficiency: Concepts, Definitions, and Assays
por: Stewart, Mark D, et al.
Publicado: (2022)

Homologous Recombination Repair Polymorphisms and the Risk for Osteosarcoma
por: Goričar, Katja, et al.
Publicado: (2015)

MMP-1 promoter polymorphism is associated with risk of radiation-induced lung injury in lung cancer patients treated with radiotherapy
por: Liu, Bo, et al.
Publicado: (2016)

Fluorodeoxyglucose positron-emission tomography ratio in non-small cell lung cancer patients treated with definitive radiotherapy
por: Kang, Hyun-Cheol, et al.
Publicado: (2013)

Association between Single Nucleotide Polymorphisms in ERCC4 and Risk of Squamous Cell Carcinoma of the Head and Neck
por: Yu, Hongping, et al.
Publicado: (2012)

Mutational landscape of homologous recombination‐related genes in small‐cell lung cancer
por: Wu, Shuo, et al.
Publicado: (2022)

Experience with Treating Lentigo Maligna with Definitive Radiotherapy
por: Fogarty, Gerald B., et al.
Publicado: (2018)

DNA repair capacity correlates with standardized uptake values from (18)F-fluorodeoxyglucose positron emission tomography/CT in patients with advanced non–small-cell lung cancer
por: Jiang, Xin (Eric), et al.
Publicado: (2018)

The Association between TGF-β1 Polymorphisms and Radiation Pneumonia in Lung Cancer Patients Treated with Definitive Radiotherapy: A Meta-Analysis
por: He, Jiazhuo, et al.
Publicado: (2014)

The Homologous Recombination Repair Pathway is Associated with Resistance to Radiotherapy in Nasopharyngeal Carcinoma
por: Wang, Zhihai, et al.
Publicado: (2020)

Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?
por: Ma, Jie-Tao, et al.
Publicado: (2017)

Impact Of Underlying Pulmonary Diseases On Treatment Outcomes In Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiotherapy
por: Kim, Hakyoung, et al.
Publicado: (2019)

Absence of a Relationship between Tumor (18)F-fluorodeoxyglucose Standardized Uptake Value and Survival in Patients Treated with Definitive Radiotherapy for Non–Small-Cell Lung Cancer
por: Lin, Ming-Yin, et al.
Publicado: (2014)

Prognostic implication of PD‐L1 polymorphisms in non‐small cell lung cancer treated with radiotherapy
por: Kang, Min Kyu, et al.
Publicado: (2021)

Dosimetric Selection for Helical Tomotherapy Based Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer or Lung Metastases
por: Chi, Alexander, et al.
Publicado: (2012)

SNPs in the TGF-β Signaling Pathway Are Associated with Increased Risk of Brain Metastasis in Patients with Non–Small-Cell Lung Cancer
por: Li, Qianxia, et al.
Publicado: (2012)

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy
por: Lebow, Emily S., et al.
Publicado: (2023)

Challenges in the target volume definition of lung cancer radiotherapy
por: Mercieca, Susan, et al.
Publicado: (2021)

Dosimetric comparison of the helical tomotherapy, volumetric-modulated arc therapy and fixed-field intensity-modulated radiotherapy for stage IIB-IIIB non-small cell lung cancer
por: Xu, Yujin, et al.
Publicado: (2017)

Ewing Sarcoma in Nepal Treated With Combined Chemotherapy and Definitive Radiotherapy
por: Jha, Anjani Kumar, et al.
Publicado: (2019)

Effectiveness of image‐guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy
por: Liang, Ji‐An, et al.
Publicado: (2020)

Radiotherapy for Thymic Carcinoma: Adjuvant, Inductive, and Definitive
por: Komaki, Ritsuko, et al.
Publicado: (2014)

A Radiomics-Based Classifier for the Progression of Oropharyngeal Cancer Treated with Definitive Radiotherapy
por: Garcia, Darwin A., et al.
Publicado: (2023)

Polymorphism of DNA Repair Genes via Homologous Recombination (HR) in Ovarian Cancer
por: Smolarz, Beata, et al.
Publicado: (2019)

Outcomes in patients with lacrimal gland carcinoma treated with definitive radiotherapy or eye-sparing surgery followed by adjuvant radiotherapy
por: Lin, Yun-Hsuan, et al.
Publicado: (2020)

Single nucleotide polymorphisms of nucleotide excision repair and homologous recombination repair pathways and their role in the risk of osteosarcoma
por: Jin, Guojun, et al.
Publicado: (2015)

Predictors of Distant Metastasis in Patients with Cervical Cancer Treated with Definitive Radiotherapy
por: Liu, Xiaoliang, et al.
Publicado: (2019)

Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy
por: Chen, Xingming, et al.
Publicado: (2016)

hMOF reduction enhances radiosensitivity through the homologous recombination pathway in non-small-cell lung cancer
por: Li, Nan, et al.
Publicado: (2019)

Definition of stereotactic body radiotherapy: Principles and practice for the treatment of stage I non-small cell lung cancer
por: Guckenberger, M., et al.
Publicado: (2013)

The Impact of Diffusion-Weighted MRI on the Definition of Gross Tumor Volume in Radiotherapy of Non-Small-Cell Lung Cancer
por: Fleckenstein, Jochen, et al.
Publicado: (2016)

Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
por: Chang, Joe Y, et al.
Publicado: (2012)

The Impact of Lymphopenia and Dosimetric Parameters on Overall Survival of Esophageal Cancer Patients Treated with Definitive Radiotherapy
por: Liu, Ming, et al.
Publicado: (2021)

The prognostic impact of supraclavicular lymph node in N3-IIIB stage non-small cell lung cancer patients treated with definitive concurrent chemo-radiotherapy
por: Oh, Dongryul, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3ondmfn9eop46ii03q73vjg8t9